论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Jha N, Sapkota Y, Shankar PR
Received 29 April 2020
Accepted for publication 15 July 2020
Published 29 July 2020 Volume 2020:13 Pages 717—725
DOI https://doi.org/10.2147/JMDH.S259708
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Purpose: The information provided in drug
advertisements (DAs) often do not follow the recommended criteria and may
promote irrational prescribing behaviors. Recently Health Action International
(HAI) formulated detailed criteria to evaluate DAs which further develop and
expand on the World Health Organization (WHO) criteria. This study was done to
evaluate DAs using both criteria.
Methods: The
study was carried out from October 2019 to January 2020 in the Department of
Pharmacology of KIST Medical College, Lalitpur, Nepal. A structured proforma
was used to collect data.
Results: Altogether
100 DAs were analyzed. Maximum (85%) were having pictorial presentations.
Majority (89%) were found to have authentic information and 3% were found to
have exaggerated information. All DAs mentioned generic name, brand name,
active drug per dosage form and approved therapeutic uses. Only 4% of DAs
mentioned about the adverse effects that can be caused by the use of these
medicines. The DAs evaluated as per the HAI criteria for pictures and images
showed that people portrayed did not seem to be Nepalese. Females and males
were portrayed differently with females being laypersons and males being
healthcare professionals. Nineteen DAs contained 33 references to scientific
literature. Thirty references contained adequate citation information to be
identified and were retrievable. Retrieved references were of high
methodological quality and from peer-reviewed journals. There was only one
graph in the DAs and it contained the number needed to treat (NNT) information.
The graph was not having statistical calculations and was not obscured by other
visual material.
Conclusion: Using
both HAI and WHO criteria for assessing the DAs was the strength of this study.
None of the DAs fulfilled all the criteria. Additionally, lack of any
information on harm in the large majority of DAs, and very limited backing of
claims with references was also seen.
Keywords: drug
advertisements, ethical criteria, evaluation, health action international,
Nepal